2019

Continued strong revenue growth in Q3 2019: +9.1% to €944m

H1 2019: another semester of strong results growth

ORPEA acquires 28% of Exelus and rolls out a comprehensive and innovative telemedicine solution across all its facilities in France

Strong H1 2019 revenue growth: +9.6% to €1,840m

Adjustment of the conversion/exchange ratio of OCEANE bonds

Strong success of the issuance of approximately €500m million of Bonds Convertible into New Shares and/or Exchangeable for Existing Shares

ORPEA launches an offering of Bonds Convertible into New Shares and/or Exchangeable for Existing Shares for a maximum nominal amount of €500m

Strong growth of 9.4% in Q1 2019 revenue to €910 million

Another year of strong earnings growth in 2018